<div><p>British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information.</p><p>The change follows similar ...

<div id="subtitle">Dyax receives $1.5 million payment as partner Eli Lilly's ImClone moves drug into development</div><div><p>Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly & Co. moved ...

<div id="subtitle">Eli Lilly will not ask for approval of osteoporosis drug based on study data, safety concerns</div><div><p>Eli Lilly & Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal ...